文献速递治疗药物监测与药物基因组学抗栓抗凝管理

影响汉族人群华法林剂量的遗传因素:队列研究系统评价与Meta分析

Genetic Factors Influencing Warfarin Dose in Han Chinese Population: A Systematic Review and Meta-Analysis of Cohort Studies.
PubMed 文献 · Clin Pharmacokinet · 2023-06-05

该系统评价与Meta分析检索多个数据库至2022年8月31日,纳入46项队列研究共10102例汉族成人患者,分析8个基因20个SNP对华法林平均日剂量(MDWD)的影响。结果显示CYP4F2 rs2108622 TT、EPHX1 rs2260863 GC、NQO1 rs1800566 TT基因型需更高MDWD,而ABCB1 rs2032582 GT/GG、CALU rs2290228 TT基因型需更低MDWD。

要点

  • CYP4F2 rs2108622 TT、EPHX1 rs2260863 GC、NQO1 rs1800566 TT基因型需更高MDWD。
  • ABCB1 rs2032582 GT/GG、CALU rs2290228 TT基因型需更低MDWD。
  • 心脏瓣膜置换术后EPHX1 rs2260863 GC基因型患者MDWD需降低7%。

核心结论

  • CYP4F2 rs2108622、GGCX rs12714145、EPHX1 rs2292566和rs2260863、ABCB1 rs2032582、NQO1 rs1800566及CALU rs2290228等SNP可能是影响汉族人群MDWD的中等强度因素。

研究设计与样本

  • 系统评价与Meta分析,检索Pubmed、Embase(Ovid)、Medline、CNKI、万方和SinoMed从建库至2022年8月31日的队列研究。
  • 最终纳入46项研究,共10102例汉族成人患者,分析8个基因20个SNP对MDWD的影响。

主要发现

  • CYP4F2 rs2108622 TT、EPHX1 rs2260863 GC或NQO1 rs1800566 TT基因型患者所需MDWD高出10%以上。
  • ABCB1 rs2032582 GT或GG、CALU rs2290228 TT基因型患者所需MDWD低10%以上。
  • 亚组分析显示心脏瓣膜置换术后EPHX1 rs2260863 GC基因型患者所需MDWD低7%。

关键数值与推荐

  • CYP4F2 rs2108622 TT、EPHX1 rs2260863 GC、NQO1 rs1800566 TT基因型对应MDWD升高超过10%。
  • ABCB1 rs2032582 GT/GG、CALU rs2290228 TT基因型对应MDWD降低超过10%。
  • 心脏瓣膜置换术后EPHX1 rs2260863 GC基因型对应MDWD降低7%。

临床怎么用

  • 在汉族患者华法林个体化给药时,除CYP2C9和VKORC1外,可参考CYP4F2、EPHX1、ABCB1、NQO1、CALU等SNP调整剂量。
  • 对携带EPHX1 rs2260863 GC基因型的心脏瓣膜置换术后患者,应考虑适当降低华法林剂量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the association of single nucleotide polymorphisms (SNPs) of various genes known to influence mean daily warfarin dose (MDWD) in the Han Chinese population. METHODS: The study is a systematic review and meta-analysis. Selected studies retrieved by searching Pubmed, Embase (Ovid), Medline, CNKI, Wanfang data, and SinoMed (from their inception to 31 August 2022) for the cohort studies assessing genetic variations that may possibly influence MDWD in Chinese patients were included. RESULT: A total of 46 studies including a total of 10,102 Han Chinese adult patients were finally included in the meta-analysis. The impact of 20 single nucleotide polymorphisms (SNPs) in 8 genes on MDWD was analyzed. The significant impact of some of these SNPs on MDWD requirements was demonstrated. Patients with CYP4F2 rs2108622 TT, EPHX1 rs2260863 GC, or NQO1 rs1800566 TT genotype required more than 10% higher MDWD. Furthermore, patients with ABCB1 rs2032582 GT or GG, or CALU rs2290228 TT genotype required more than 10% lower MDWD. Subgroup analysis showed that patients with EPHX1 rs2260863 GC genotype required 7% lower MDWD after heart valve replacement (HVR). CONCLUSION: This is the first systematic review and meta-analysis assessing the association between single nucleotide polymorphisms (SNPs) of various genes known to influence MDWD besides CYP2C9 and VKORC1 in the Han Chinese population. CYP4F2 (rs2108622), GGCX (rs12714145), EPHX1 (rs2292566 and rs2260863), ABCB1 (rs2032582), NQO1 (rs1800566), and CALU (rs2290228) SNPs might be moderate factors affecting MDWD requirements. REGISTERED INFORMATION: PROSPERO International Prospective Register of Systematic Reviews (CRD42022355130).

来源:Clin Pharmacokinet,查看原文。版权归原作者所有。

引用

  1. Zhao Z, Zhao F, Wang X, et al. Genetic Factors Influencing Warfarin Dose in Han Chinese Population: A Systematic Review and Meta-Analysis of Cohort Studies. Clin Pharmacokinet. 2023. PMID: 37273173. doi:10.1007/s40262-023-01258-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。